New antifungal drug's belly penetration tested in ICU patients
NCT ID NCT07093203
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the antifungal drug rezafungin moves into the abdominal fluid of critically ill patients with a serious fungal infection after abdominal surgery. Researchers will measure drug levels in the blood and belly fluid of 20 patients. The goal is to see if enough drug reaches the infection site to guide future dosing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- rezafungin
- What this could lead to
- If successful, this could help doctors determine the right dose of rezafungin for critically ill patients with abdominal fungal infections.
- What could go wrong
- This is a very small, early pharmacokinetic study (20 patients) that only measures drug levels, not treatment outcomes. It may not lead to changes in clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL SURGERY PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de Nancy
RECRUITINGVandœuvre-lès-Nancy, Lorraine, 54500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a quick PCR test speed up lifesaving fungal infection diagnosis?
- Liver ultrasound may offer a new window into heart health in the ICU
- Hospital art program aims to get surgery patients out of bed faster
- Poop pills for ICU patients? new trial tests fecal transplants for feeding troubles
- New hospital gown aims to give surgery patients privacy and comfort
- New study aims to make pain relief safer after abdominal surgery